secwatch.observer — SEC 8-K summary
======================================

Issuer:     Atara Biotherapeutics, Inc. (ATRA)
CIK:        0001604464
Form:       8-K
Filed at:   2024-03-29T23:59:59+00:00
Accession:  0000950170-24-038690
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Eric Dobmeier to not stand for re-election at Atara's 2024 annual meeting
--------------------------------------------------------------------------------

- Eric Dobmeier notified Atara on March 26, 2024, he will not stand for re-election at the 2024 annual meeting.
- He will continue as director until his term expires at the 2024 Annual Meeting.
- No disagreement with Board or management; decision not related to operations, policies, or practices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604464/000095017024038690/0000950170-24-038690-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604464/000095017024038690/atra-20240326.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-038690

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer